Medaxiom Blog

A curated feed of cardiovascular articles and posts


Stay up-to-date on the latest opinions, trends, and issues in cardiovascular healthcare with MedAxiom’s weekly blog posts.  New posts every Thursday.

Search

I want healthcare like my dog!!

Thursday, June 6, 2019 | Joel Sauer | 2 Comments


Human and animal healthcare are different, but why shouldn’t we expect the same level of communication and care coordination that vets provide. Joel Sauer explains why he feels the care his family dog Roxy has received has made such a difference from maintaining regular check-ups to making more advanced care decisions.

Read Full Story »

Registry Data Getting the most value out of this important asset.

Friday, May 31, 2019 | Ginger Biesbrock | 0 Comments


Most programs are involved with at least one registry but struggle to effectively utilize the data. Ginger Biesbrock explains three areas that need to be managed in order to ensure this valuable tool is not left unused.

Read Full Story »

Is Time-Based Billing and Documentation Something We Should Think About?

Friday, May 24, 2019 | Nicole Knight | 0 Comments


Time is central to the Evaluation and Management (E/M) coding system and changes from CMS and the American Medical Association (AMA) could impact documentation requirements in this area. Nicole Knight provides a few things you may want to look at as you evaluate your time-based coding effectiveness, training needs and future opportunities.

Read Full Story »

7 Tips for Improving Employee Engagement

Thursday, May 16, 2019 | Lori Walsh | 0 Comments


It’s important to create a formal process for acclimating and developing each new employee. Lori Walsh provides 7 tips to help improve employee engagement and provide that continuous line of communication.

Read Full Story »

The Imminent Growth of TAVR and BPCI-A

Thursday, May 9, 2019 | Joseph Sasson | 0 Comments


There are changes coming for Transcatheter Aortic Valve Replacement (TAVR) that will effect how we contract to provide these services. Joe Sasson explains what we know now and why he believes these changes mean growth for TAVR and BPCI-A.

Read Full Story »